Recent News

• 02.10.2026 - OraSure to Launch OraQuick™ HIV Self-Test in Canada
• 02.09.2026 - OraSure to Announce Fourth Quarter 2025 Financial Results and Host Earnings Call on February 25th
• 01.15.2026 - OraSure Technologies Confirms Receipt of Director Nominations from Altai Capital
• 12.17.2025 - OraSure Technologies Issues Statement Regarding Altai Capital’s Intent to Nominate Director Candidates
• 11.17.2025 - OraSure to Participate in Upcoming Investor Conference
• 11.05.2025 - OraSure Announces Third Quarter 2025 Financial Results

Recent Filings

• 01.15.2026 - DFAN14A Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material
• 01.15.2026 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 01.15.2026 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 01.05.2026 - 8-K Current report
• 01.05.2026 - EX-99.1 EX-99.1
• 12.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.17.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 12.17.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 12.04.2025 - 144 Report of proposed sale of securities
• 12.02.2025 - 4 Statement of changes in beneficial ownership of securities